1. Home
  2. MIRM vs ANF Comparison

MIRM vs ANF Comparison

Compare MIRM & ANF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIRM
  • ANF
  • Stock Information
  • Founded
  • MIRM 2018
  • ANF 1892
  • Country
  • MIRM United States
  • ANF United States
  • Employees
  • MIRM N/A
  • ANF N/A
  • Industry
  • MIRM Biotechnology: Pharmaceutical Preparations
  • ANF Clothing/Shoe/Accessory Stores
  • Sector
  • MIRM Health Care
  • ANF Consumer Discretionary
  • Exchange
  • MIRM Nasdaq
  • ANF Nasdaq
  • Market Cap
  • MIRM 3.8B
  • ANF 3.8B
  • IPO Year
  • MIRM 2019
  • ANF 1996
  • Fundamental
  • Price
  • MIRM $72.65
  • ANF $72.55
  • Analyst Decision
  • MIRM Strong Buy
  • ANF Buy
  • Analyst Count
  • MIRM 11
  • ANF 10
  • Target Price
  • MIRM $79.00
  • ANF $118.20
  • AVG Volume (30 Days)
  • MIRM 560.3K
  • ANF 2.1M
  • Earning Date
  • MIRM 11-04-2025
  • ANF 11-25-2025
  • Dividend Yield
  • MIRM N/A
  • ANF N/A
  • EPS Growth
  • MIRM N/A
  • ANF 13.04
  • EPS
  • MIRM N/A
  • ANF 10.58
  • Revenue
  • MIRM $429,161,000.00
  • ANF $5,099,754,000.00
  • Revenue This Year
  • MIRM $53.14
  • ANF $7.63
  • Revenue Next Year
  • MIRM $19.83
  • ANF $3.98
  • P/E Ratio
  • MIRM N/A
  • ANF $6.86
  • Revenue Growth
  • MIRM 62.33
  • ANF 9.34
  • 52 Week Low
  • MIRM $36.88
  • ANF $65.40
  • 52 Week High
  • MIRM $78.55
  • ANF $164.80
  • Technical
  • Relative Strength Index (RSI)
  • MIRM 52.77
  • ANF 40.94
  • Support Level
  • MIRM $68.34
  • ANF $66.65
  • Resistance Level
  • MIRM $71.96
  • ANF $76.18
  • Average True Range (ATR)
  • MIRM 2.53
  • ANF 2.24
  • MACD
  • MIRM -0.13
  • ANF 0.98
  • Stochastic Oscillator
  • MIRM 56.54
  • ANF 61.94

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

About ANF Abercrombie & Fitch Company

Abercrombie & Fitch Co is a specialty retailer that sells casual clothing, personal-care products, and accessories for men, women, and children. It sells direct to consumers through its stores and websites, which include the Abercrombie & Fitch, Abercrombie kids, and Hollister brands. Most stores are in the United States, but the company does have many stores in Canada, Europe, and Asia. All stores are leased. Abercrombie ships to well over 100 countries via its websites. The company sources its merchandise from dozens of vendors that are primarily located in Asia and Central America. Abercrombie has two distribution centers in Ohio to support its North American operations. It uses third-party distributors for sales in Europe and Asia.

Share on Social Networks: